Richard D Hamlin

This inventor holds 9 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 4 EPO patents. Top assignees: Teikoku Pharma USA, Inc., Alza Corporation. Active years: 1998-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard D Hamlin. Retrieved from https://idiyas.com/inventor/richard-d-hamlin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 177(Granted Patents)

Company Filing History:

7 out of 52

Teikoku Pharma USA, Inc.

Years Active: 1998-2021

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10918607 - Propynylaminoindan transdermal compositions (2021-02-16),

2. 9913812 - Methods for the treatment of skin neoplasms (2018-03-13),

3. 9827207 - Propynylaminoindan transdermal compositions (2017-11-28),

4. 9597301 - Propynylaminoindan transdermal compositions (2017-03-21),

5. 9205061 - Propynylaminoindan transdermal compositions (2015-12-08),

6. 9119799 - Transdermal compositions comprising an active agent layer and an active agent conversion layer (2015-09-01),

7. 9017723 - Propynylaminoindan transdermal compositions (2015-04-28),

8. 6267984 - Skin permeation enhancer compositions comprising a monoglyceride and ethyl palmitate (2001-07-31),

9. 5843468 - Skin permeation enhancer compositions comprising glycerol monolaurate (1998-12-01),

Title: The Innovative Contributions of Richard D. Hamlin

Introduction

Richard D. Hamlin is a notable inventor based in Newark, California, with a remarkable portfolio of nine patents. His work primarily focuses on advancements in pharmaceutical compositions and methods for treating various medical conditions.

Latest Patents

Among his latest patents, Hamlin has developed transdermal compositions that utilize propynylaminoindan, such as Rasagiline. These compositions feature a matrix that includes a pressure-sensitive adhesive made from an acrylate copolymer and a cationic acrylic copolymer. Additionally, he has provided methods for treating skin neoplasms using monoamine oxidase inhibitors, along with pharmaceutical compositions and kits that incorporate these inhibitors.

Career Highlights

Throughout his career, Richard D. Hamlin has made significant contributions to the pharmaceutical industry. He has worked with reputable companies, including Teikoku Pharma USA, Inc. and Alza Corporation, where he has applied his expertise in drug formulation and delivery systems.

Collaborations

Hamlin has collaborated with several professionals in his field, including Jianye Wen and Amit K. Jain, enhancing the scope and impact of his innovative work.

Conclusion

Richard D. Hamlin's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His innovative approaches continue to influence the development of effective medical treatments.

Profile summary based on public USPTO records.